Sign In
Buy RGEN
$121.73
+0.600 (+0.495%)
At Close: Jun 03, 2026
10 Biggest Price Target Changes For Thursday
11:35am, Thursday, 28'th Apr 2022 Benzinga
Needham lowered MKS Instruments, Inc. (NASDAQ: MKSI) price target from $185 to $175. MKS Instruments shares rose 3.6% to $116.01 in pre-market trading.
Piper Sandler cut the price target for PayPal
Why Repligen Is Up More Than 10% Today
04:10pm, Wednesday, 27'th Apr 2022 The Motley Fool
A stronger-than-expected earnings report calls months of the stock's weakness into question.
Repligen Corporation (RGEN) CEO Tony Hunt on Q1 2022 Results - Earnings Call Transcript
02:58pm, Wednesday, 27'th Apr 2022
Repligen Corporation (NASDAQ:RGEN ) Q1 2022 Results Earnings Conference Call April 27, 2022 8:30 AM ET Company Participants Sondra Newman - Vice President and Global Head of Investor Relations Tony Hu
Repligen (RGEN) Beats Q1 Earnings and Revenue Estimates
12:45pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Repligen (RGEN) delivered earnings and revenue surprises of 27.78% and 12.45%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
These 20 highly rated stocks are expected to rise at least 70% over the next year
10:42am, Wednesday, 20'th Apr 2022 MarketWatch
Favored companies include Uber, General Motors and Twilio.
2 Reasons to Buy Repligen, and 1 Reason to Sell
02:37pm, Thursday, 14'th Apr 2022 The Motley Fool
Management has executed its strategy well, but a potential risk is looming.
2 Reasons to Buy Repligen, and 1 Reason to Sell
10:37am, Thursday, 14'th Apr 2022
Management has executed its strategy well, but a potential risk is looming.
Repligen to Report First Quarter 2022 Financial Results
11:30am, Wednesday, 13'th Apr 2022 GlobeNewswire Inc.
Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT
Repligen to Report First Quarter 2022 Financial Results
07:30am, Wednesday, 13'th Apr 2022
Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT
Elephant Tracking: How to Spot the Market's Next Mega Winners BEFORE They Take Off
04:26pm, Monday, 11'th Apr 2022
If you follow an elephant's tracks, you find an elephant. If you follow a large money manager, you'll find the winners they've identified.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
01:56pm, Monday, 11'th Apr 2022 Zacks Investment Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2 Top Biotech Stocks to Buy for the Long Haul
02:30pm, Thursday, 07'th Apr 2022 The Motley Fool
Repligen and Exact Sciences have a proven track record with significant opportunities for continued growth.
Should Invesco S&P MidCap 400 Pure Growth ETF (RFG) Be on Your Investing Radar?
10:20am, Tuesday, 29'th Mar 2022 Zacks Investment Research
Style Box ETF report for RFG
Should Vanguard S&P MidCap 400 Growth ETF (IVOG) Be on Your Investing Radar?
10:20am, Wednesday, 23'rd Mar 2022 Zacks Investment Research
Style Box ETF report for IVOG
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
10:20am, Monday, 21'st Mar 2022 Zacks Investment Research
Smart Beta ETF report for PBE
